Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess physical functionality changes over a minimum of 9
weeks in patients with non-malignant chronic low back pain who are taking short-acting
opioids (narcotic pain medications) for 4 or more weeks, and who start taking the long-acting
opioid fentanyl in the form of a transdermal (skin) patch.